The store will not work correctly when cookies are disabled.
5-(4-methoxyphenyl)-7-[2-(4-methoxyphenyl)vinyl]-2-methyl-5H-thiazolo[3,2-a]pyrimidine
ID: ALA4757444
PubChem CID: 162656346
Max Phase: Preclinical
Molecular Formula: C23H22N2O2S
Molecular Weight: 390.51
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(/C=C/C2=CC(c3ccc(OC)cc3)N3C=C(C)SC3=N2)cc1
Standard InChI: InChI=1S/C23H22N2O2S/c1-16-15-25-22(18-7-12-21(27-3)13-8-18)14-19(24-23(25)28-16)9-4-17-5-10-20(26-2)11-6-17/h4-15,22H,1-3H3/b9-4+
Standard InChI Key: TYKJZNPCWWCYQU-RUDMXATFSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
24.6423 -4.2015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6411 -5.0210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3492 -5.4300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0588 -5.0205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0560 -4.1979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3474 -3.7926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7622 -3.7866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4714 -4.1925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1776 -3.7813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8854 -4.1899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5895 -3.7821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1713 -2.9659 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2966 -4.1891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2952 -5.0074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0021 -5.4159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7108 -5.0073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7082 -4.1859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0007 -3.7810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8815 -2.5565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5866 -2.9660 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.1939 -2.4219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8642 -1.6762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0531 -1.7594 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.4190 -5.4149 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.9331 -5.4291 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.2257 -5.0199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4201 -6.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2746 -0.9695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
9 12 1 0
10 11 1 0
11 20 1 0
19 12 2 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
11 13 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 1 0
16 24 1 0
2 25 1 0
25 26 1 0
24 27 1 0
22 28 1 0
M END
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 390.51 | Molecular Weight (Monoisotopic): 390.1402 | AlogP: 5.62 | #Rotatable Bonds: 5 |
Polar Surface Area: 34.06 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 5.16 | CX LogP: 4.49 | CX LogD: 4.49 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.66 | Np Likeness Score: -0.14 |
References
1. Al-Rashood ST,Elshahawy SS,El-Qaias AM,El-Behedy DS,Hassanin AA,El-Sayed SM,El-Messery SM,Shaldam MA,Hassan GS. (2020) New thiazolopyrimidine as anticancer agents: Synthesis, biological evaluation, DNA binding, molecular modeling and ADMET study., 30 (23.0): [PMID:33068712] [10.1016/j.bmcl.2020.127611] |